Industries

Life Sciences Litigation

Overview

CRA’s life sciences litigation support services are grounded in a comprehensive understanding of pharmaceutical, biotechnology, medical device, and diagnostic markets. For more than 30 years, our experts have consulted with major life science companies, law firms, and regulatory agencies around the globe. We provide clients with the industry and analytical expertise needed to solve our clients’ most complex issues.

CRA has a reputation for delivering rigorous analysis and expert testimony. Economic expertise is complemented by experience assisting life sciences companies with business and policy issues. This combination allows CRA to provide effective expert testimony and support.

01

CRA opines on irreparable harm at Delaware Chancery Court

In a matter before the Delaware Chancery Court, CRA was retained by an early-stage pharmaceutical manufacturer whose trade secrets had been misappropriated...
View engagement
02

CRA addressed a claim that a company had improperly failed to pay required development milestones upon termination of a drug development program

In litigation before the Delaware Court of Chancery, a CRA expert was asked to address the basis for a company’s decision to terminate the development of a...
View engagement
03

Economic analysis in a product hopping litigation

This case involved a blood thinner drug whose initial patent had expired. The brand company improved the product and obtained additional patents on those...
View engagement